Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Legend Biotech Corporation - American Depositary Shares (NQ:LEGN)

29.35 +1.36 (+4.86%)
Streaming Delayed Price Updated: 9:43 AM EDT, May 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 168,081
Open 27.60
Bid (Size) 29.26 (500)
Ask (Size) 29.40 (100)
Prev. Close 27.99
Today's Range 27.19 - 29.44
52wk Range 16.24 - 45.30
Shares Outstanding 308,456,852
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Legend Biotech Announces Presentations at ASCO 2026
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
A China Tech Fund Opens a Biotech Position — Here's What That Actually Signals ↗
Legend Biotech develops cell therapies for cancer, with a pipeline spanning hematologic malignancies and solid tumors. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+36.4%
+36.4%
1 Month
+16.4%
+16.4%
3 Month
+59.9%
+59.9%
6 Month
+6.6%
+6.6%
1 Year
+3.6%
+3.6%

More News

Read More
News headline image
With YMM Down 29%, First Beijing Bought 13 Million More Shares ↗
Via The Motley Fool
Topics Regulatory Compliance
Legend Biotech (NASDAQ:LEGN) Q1 2026 Revenue Surges on CARVYKTI Growth, but EPS Falls Short ↗
Via Chartmill
Legend Biotech Corp. (NASDAQ:LEGN) Reports Mixed Q4 2025 Results, Beats on EPS ↗
Via Chartmill
News headline image
Legend Biotech (LEGN) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Legend Biotech Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Legend Biotech Reports First Quarter 2026 Results and Recent Highlights
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Is Yum China a Buy After Investment Firm Matthews Purchased Shares Worth $12.57 Million? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Matthews Just Slashed Its Futu Position -- Here’s Why That Matters ↗
Via The Motley Fool
News headline image
Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Why Legend Biotech Stock Crushed the Market on Monday ↗
Via The Motley Fool
News headline image
Legend Biotech (LEGN) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Legend Biotech (LEGN) Q2 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Legend Biotech (LEGN) Q4 2024 Earnings Transcript ↗
Via The Motley Fool
Topics Earnings Economy World Trade
News headline image
Legend Biotech (LEGN) Q1 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
This Fintech Stock Is Up 21% in a Year as Profits Surge, but One Fund's Nearly $300 Million Sale Cut Its Stake in Half ↗
Via The Motley Fool
News headline image
Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results
From Legend Biotech USA Inc.
Via GlobeNewswire
These stocks are gapping in today's session ↗
Via Chartmill
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
HHLR Advisors Fully Exits Baidu as AI Push Tests Its Advertising-Funded Model ↗
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Legend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
From Legend Biotech USA Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Legend Biotech Corporation - American Depositary Shares publicly traded?
Yes, Legend Biotech Corporation - American Depositary Shares is publicly traded.
What exchange does Legend Biotech Corporation - American Depositary Shares trade on?
Legend Biotech Corporation - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Legend Biotech Corporation - American Depositary Shares?
The ticker symbol for Legend Biotech Corporation - American Depositary Shares is LEGN on the Nasdaq Stock Market
What is the current price of Legend Biotech Corporation - American Depositary Shares?
The current price of Legend Biotech Corporation - American Depositary Shares is 29.35
When was Legend Biotech Corporation - American Depositary Shares last traded?
The last trade of Legend Biotech Corporation - American Depositary Shares was at 05/22/26 09:43 AM ET
What is the market capitalization of Legend Biotech Corporation - American Depositary Shares?
The market capitalization of Legend Biotech Corporation - American Depositary Shares is 9.05B
How many shares of Legend Biotech Corporation - American Depositary Shares are outstanding?
Legend Biotech Corporation - American Depositary Shares has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.